ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,817Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 944

$556K Total Retail Price of All Prescriptions

Rank: 157 out of 944

465 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 465 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 465 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,387 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 846 743 1 1
LISINOPRIL 530 489 2 3
LEVOTHYROXINE SODIUM 406 332 3 2
OMEPRAZOLE 400 352 4 4
HYDROCHLOROTHIAZIDE 356 327 5 9
AMLODIPINE BESYLATE 340 308 6 5
ATENOLOL 288 259 7 11
METFORMIN HCL 280 231 8 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 244 232 9 29
MIRTAZAPINE 221 208 10 35
ZOLPIDEM TARTRATE 201 161 11 25
METOPROLOL SUCCINATE 197 188 12 14
FUROSEMIDE 193 187 13 6
SERTRALINE HCL 192 179 14 23
TRAMADOL HCL 191 173 15 21
METOPROLOL TARTRATE 187 153 16 8
WARFARIN SODIUM 175 171 17 7
LOSARTAN POTASSIUM 159 152 18 16
PRAVASTATIN SODIUM 158 129 19 17
GABAPENTIN 157 138 20 18
TRIAMTERENE-HCTZ 156 140 21 33
TAMSULOSIN HCL 146 135 22 27
ALENDRONATE SODIUM 138 121 23 20
HYDROCODONE-ACETAMINOPHEN 131 99 S3 24 10
ATORVASTATIN CALCIUM 121 107 25 13
POTASSIUM CHLORIDE 110 89 26 15
GLIPIZIDE 110 89 26 51
CARVEDILOL 108 108 28 30
ALLOPURINOL 104 91 29 22
VENLAFAXINE HCL ER 103 86 30 84
NAMENDA 95 95 31 37
DONEPEZIL HCL 94 94 32 24
RANITIDINE HCL 87 66 33 42
ADVAIR DISKUS 84 84 34 31
TRAZODONE HCL 84 47 34 45
GEMFIBROZIL 81 78 36 72
CITALOPRAM HBR 80 63 37 19
FLUTICASONE PROPIONATE 76 52 38 40
FINASTERIDE 72 72 39 83
LOVASTATIN 68 59 40 26
DIOVAN 66 62 41 38
GLYBURIDE 64 61 R 42 63
NAPROXEN 64 64 42 113
DIGOXIN 62 62 44 39
OXYBUTYNIN CHLORIDE ER 61 37 45 102
OLANZAPINE 60 49 46 125
OXYBUTYNIN CHLORIDE 58 35 47 94
PANTOPRAZOLE SODIUM 58 45 47 34
GLIMEPIRIDE 56 55 49 47
LYRICA 53 46 50 114
NIASPAN 53 44 50 76
DOXAZOSIN MESYLATE 52 52 52 60
GLYBURIDE-METFORMIN HCL 51 51 R 53 132
FAMOTIDINE 51 51 53 74
NADOLOL 50 49 55 209
VESICARE 50 50 55 138
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.